Thalys Medical Technology Group Corporation (SHA:603716)

China · Delayed Price · Currency is CNY

14.76

+0.37 (2.57%)

Jun 29, 2026, 3:00 PM CST

6.11% (1Y)

Market Cap	3.16B +32.4%
Revenue (ttm)	971.32M -39.8%
Net Income	-210.48M
EPS	-1.04
Shares Out	214.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,677,912
Open	14.25
Previous Close	14.39
Day's Range	13.87 - 15.24
52-Week Range	13.78 - 38.12
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2004

Employees 1,045

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603716

Full Company Profile

Financial Performance

In 2025, SHA:603716's revenue was 1.08 billion, a decrease of -40.52% compared to the previous year's 1.81 billion. Losses were -207.28 million, -0.93% less than in 2024.

Financial Statements